Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OSE Immuno (OSE FP)
Watchlist
36
Analysis
Health Care
•
France
OSE Immunotherapeutics SA is a biotechnology company based in France, developing immunotherapy products against invasive/metastatic late-stage cancers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
OSE Immuno
•
22 Jan 2024 19:10
•
Issuer-paid
OSE Immunotherapeutics - Active year ahead for proprietary programmes
OSE has refreshed its outlook for 2024, including the commencement of the confirmatory Phase III trial for lead asset Tedopi (an off-the-shelf,...
Edison Investment Research
Follow
212 Views
Share
bullish
•
OSE Immuno
•
12 Dec 2023 19:10
•
Issuer-paid
OSE Immunotherapeutics - Timely FR104/VEL-101 update with Phase II plans
OSE Immunotherapeutics (OSE) has shared a positive update on the FIRsT clinical trial assessing FR104/VEL-101 (an anti-CD28 monoclonal antibody) as...
Edison Investment Research
Follow
257 Views
Share
bullish
•
OSE Immuno
•
28 Nov 2023 07:10
•
Issuer-paid
OSE Immunotherapeutics - Collaboration bolsters upcoming Tedopi Phase III
OSE Immunotherapeutics (OSE) has announced a collaboration with GenDx for the development and validation of a companion diagnostic screening test...
Edison Investment Research
Follow
213 Views
Share
bullish
•
OSE Immuno
•
18 Oct 2023 01:10
•
Issuer-paid
OSE Immunotherapeutics - Anticipation builds with positive OSE-279 data
At the AACR-NCI-EORTC conference in Boston, OSE presented the initial positive data supporting the potential efficacy of its anti-PD1 monoclonal...
Edison Investment Research
Follow
215 Views
Share
bullish
•
OSE Immuno
•
03 Oct 2023 19:10
•
Issuer-paid
OSE Immunotherapeutics - Maintaining momentum after an active H123
OSE Immunotherapeutics (OSE) has announced its H123 results, providing an operational and a financial update. Highlights from the period included...
Edison Investment Research
Follow
238 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x